Derouane, Françoise
Desgres, Manon
Moroni, Camilla
Ambroise, Jérôme
Berlière, Martine
Van Bockstal, Mieke R.
Galant, Christine
van Marcke, Cédric
Vara-Messler, Marianela
Hutten, Stefan J.
Jonkers, Jos
Mourao, Larissa
Scheele, Colinda L. G. J.
Duhoux, Francois P.
Corbet, Cyril
Funding for this research was provided by:
Fonds De La Recherche Scientifique - FNRS
Fonds Joseph Maisin
Fondation contre le Cancer
Fondation Saint Luc
Université Catholique de Louvain
Article History
Received: 8 August 2023
Accepted: 13 February 2024
First Online: 19 February 2024
Declarations
:
: Patients with early TNBC, eligible for NAC, were recruited, retrospectively and prospectively, at CUSL (NCT03314870, ethics committee number 2017/25JUL/376). For the retrospective cohort, recruited from 2012 to 2017, no informed consent was needed while for the prospective cohort, recruited from 2018 to 2022, subjects gave informed consent.
: Not applicable.
: The authors declare that they have no competing interests.